This HTML5 document contains 73 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
n12http://dx.doi.org/10.1007/
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n10http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
n5https://scigraph.springernature.com/pub.10.1007/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q74107584
rdf:type
wikibase:Item
schema:description
artículu científicu espublizáu n'avientu de 2001 наукова стаття, опублікована в грудні 2001 مقالة علمية تنشرت ف 1 دجنبر 2001 wetenschappelijk artikel im Dezember 2001 veröffentlichter wissenschaftlicher Artikel scientific article published on 01 December 2001
p:P577
wds:Q74107584-48C92FF9-7E9D-416C-B4D2-60EF9C366081
wdt:P577
2001-12-01T00:00:00Z
p:P2888
wds:Q74107584-913750BF-EF7F-4E59-9AA3-5C6E14272E73
wdt:P2888
n5:s004150170028
p:P2093
wds:Q74107584-A8BF800D-841D-452C-8EE7-E027A3DB4A03 wds:Q74107584-A12C5CA8-0CE5-4E7A-BA67-42BF874E8E4D wds:Q74107584-846C77E0-6ECF-4830-AEB7-80FCAAFE438F wds:Q74107584-8B776A50-D393-4749-B71C-B7E66E377EA9 wds:Q74107584-49FB90EB-A8F5-4673-9BEA-D46AA256537A wds:Q74107584-25A64CDA-050B-4810-BB41-C4C9D7FA2BA5 wds:Q74107584-31C9097B-C3D8-4462-9F0F-61F1D62F3963 wds:Q74107584-1DA08E4F-FCFE-4991-8B8A-C47E6C05E602 wds:Q74107584-177BE72B-620B-4C05-8135-3424830B4475 wds:Q74107584-1A163B2A-5875-4F5F-8101-E62349791C6D wds:Q74107584-04AA9FB9-C007-4A14-81E0-434E057E94BE
wdt:P2093
E Auff A Richardson C Brenneis H Streitova M Bares J Müller W Poewe H Hortova J Wissel P Kanovsky P Schnider
rdfs:label
Efficacy and safety of a standardised 500 unit dose of Dysport (clostridium botulinum toxin type A haemaglutinin complex) in a heterogeneous cervical dystonia population: results of a prospective, multicentre, randomised, double-blind, placebo-contr Efficacy and safety of a standardised 500 unit dose of Dysport (clostridium botulinum toxin type A haemaglutinin complex) in a heterogeneous cervical dystonia population: results of a prospective, multicentre, randomised, double-blind, placebo-contr
skos:prefLabel
Efficacy and safety of a standardised 500 unit dose of Dysport (clostridium botulinum toxin type A haemaglutinin complex) in a heterogeneous cervical dystonia population: results of a prospective, multicentre, randomised, double-blind, placebo-contr Efficacy and safety of a standardised 500 unit dose of Dysport (clostridium botulinum toxin type A haemaglutinin complex) in a heterogeneous cervical dystonia population: results of a prospective, multicentre, randomised, double-blind, placebo-contr
schema:name
Efficacy and safety of a standardised 500 unit dose of Dysport (clostridium botulinum toxin type A haemaglutinin complex) in a heterogeneous cervical dystonia population: results of a prospective, multicentre, randomised, double-blind, placebo-contr Efficacy and safety of a standardised 500 unit dose of Dysport (clostridium botulinum toxin type A haemaglutinin complex) in a heterogeneous cervical dystonia population: results of a prospective, multicentre, randomised, double-blind, placebo-contr
p:P50
wds:Q74107584-53FD0B46-B63D-4C18-8E8E-97C8AA23FB56 wds:Q74107584-550C41D6-B091-4902-9BEB-D17F78E42563 wds:Q74107584-01869790-6214-4595-82E9-DCEDCF98F0C7
wdt:P50
wd:Q45291752 wd:Q40272129 wd:Q45305534
p:P1476
wds:Q74107584-954E1A53-24C6-41E8-BD84-0B8CD10353A7
wdt:P1476
Efficacy and safety of a standardised 500 unit dose of Dysport (clostridium botulinum toxin type A haemaglutinin complex) in a heterogeneous cervical dystonia population: results of a prospective, multicentre, randomised, double-blind, placebo-controlled, parallel group study
p:P304
wds:Q74107584-1732D62A-0E3A-45B4-B995-2F346C5ECEE0
wdt:P304
1073-1078
p:P31
wds:Q74107584-8F19D504-2F9B-4C0A-82BB-33CF23850BC5
wdt:P31
wd:Q13442814
p:P921
wds:Q74107584-43D2DA8A-CD19-4567-8E45-B081A2B7CF46 wds:Q74107584-8B9FDC09-11B0-4435-8B6C-78CD0AC8C397 wds:Q74107584-B716ECAB-7E76-4B91-B18D-98DBF22F9D55 wds:Q74107584-9CD70CA9-1051-4D1B-B3F8-2832700DD450
wdt:P921
wd:Q269829 wd:Q131268 wd:Q4095199 wd:Q6152510
p:P698
wds:Q74107584-31EF8957-F11A-4F34-8E31-446AF7824C4F
wdtn:P698
n10:12013585
wdt:P698
12013585
p:P1433
wds:Q74107584-1CFC3A3F-110B-4D70-BF6C-BF05FCCCA854
wdt:P1433
wd:Q6295649
p:P433
wds:Q74107584-0144C02E-8172-42B4-A928-2286AA09C22F
p:P478
wds:Q74107584-B25546F0-1058-41AD-ADE4-F027E59A1468
wdt:P433
12
wdt:P478
248
p:P356
wds:Q74107584-0C7D877F-9A6E-4EC9-98F8-2894FEA24E0E
wdtn:P356
n12:S004150170028
wdt:P356
10.1007/S004150170028
p:P6179
wds:Q74107584-010B9E66-DE69-4576-A5F3-9481644E747C
wdt:P6179
1050331276